4-dodecyl-N-(1,3,4-thiadiazol-2-yl)benzenesulfonamide,
PHT 427,
PHT-427,
PHT427,
PHT-427,
1191951-57-1,
PHT 427,
4-dodecyl-N-(1,3,4-thiadiazol-2-yl)benzenesulfonamide,
PHT427,
CHEMBL595583,
CS-0223,
AK203977,
4-Dodecyl-N-1,3,4-thiadiazol-2-ylbenzenesulfonamide,
BYWWNRBKPCPJMG-UHFFFAOYSA-N,
MLS006011014,
SCHEMBL283080,
GTPL8009,
Akt Inhibitor XIV(PHT-427),
KS-00001CVH,
DTXSID90658014,
EX-A131,
PHT 427;PHT427,
C20H31N3O2S2,
HMS3655M03,
BCP02902,
2654AH,
BDBM50304369,
MFCD18384970,
s1556,
ZINC49757540,
AKOS024458243,
API0007784,
RL00742,
SB17376,
NCGC00346547-01,
AC-30264,
BC660061,
DA-47470,
HY-12063,
SC-96636,
SMR004702812,
BCP0726000128,
AB0088766,
FT-0716636,
SW219686-1,
Q-9152,
J-004083,
J-515259,
4-Dodecyl-N-1,3,4-thiadiazol-2-yl-benzenesulfonamide,
Benzenesulfonamide, 4-dodecyl-N-1,3,4-thiadiazol-2-yl-,
4-Dodecyl-N-(1,3,4-thiadiazol-2-yl)benzene-1-sulfonamide,
PHT427, PHT 427, 1191951-57-1,
D0M9QJ,
cc-348,
ACN-039817,
A5884,
A11032,